PIK3CD and cancer: As a downstream molecule of PI3K/AKT pathway, P27 is regulated by PI3K/AKT pathway, and the abnormal change of p27 significantly affects cell proliferation and cell cycle, making it a target to be considered in cancer therapy (246, 247).